Cargando…

Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients

BACKGROUND: Graves’ disease (GD) is the most common cause of hyperthyroidism and can cause cardiac changes, such as pulmonary hypertension. METHODS: This is a prospective study in which we obtained demographic, clinical, laboratory data and characteristics of the GD, in addition to investigating car...

Descripción completa

Detalles Bibliográficos
Autores principales: Araruna, Larisse Vieira Mendes, de Oliveira, Daniela Camargo, Pereira, Mônica Corso, Moura Neto, Arnaldo, Tambascia, Marcos Antonio, Zantut-Wittmann, Denise Engelbrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772033/
https://www.ncbi.nlm.nih.gov/pubmed/35069439
http://dx.doi.org/10.3389/fendo.2021.780397
_version_ 1784635755094605824
author Araruna, Larisse Vieira Mendes
de Oliveira, Daniela Camargo
Pereira, Mônica Corso
Moura Neto, Arnaldo
Tambascia, Marcos Antonio
Zantut-Wittmann, Denise Engelbrecht
author_facet Araruna, Larisse Vieira Mendes
de Oliveira, Daniela Camargo
Pereira, Mônica Corso
Moura Neto, Arnaldo
Tambascia, Marcos Antonio
Zantut-Wittmann, Denise Engelbrecht
author_sort Araruna, Larisse Vieira Mendes
collection PubMed
description BACKGROUND: Graves’ disease (GD) is the most common cause of hyperthyroidism and can cause cardiac changes, such as pulmonary hypertension. METHODS: This is a prospective study in which we obtained demographic, clinical, laboratory data and characteristics of the GD, in addition to investigating cardiorespiratory function, focusing on the detection of pulmonary hypertension. Patients were separated into two groups: thyrotoxicosis and euthyroidism. Ninety patients with GD of both sexes, over 18 years of age, were included. The cardiorespiratory assessment included an echocardiographic evaluation, a questionnaire of specific symptoms, spirometry and a six-minute walk test. RESULTS: The hyperthyroid group included 42 patients (47.73%) and the euthyroid group 46 patients (52.27%); 78 were women (86.67%). The prevalence of pulmonary hypertension between the hyperthyroidism (48.57%) and the euthyroidism (29.41%) groups was not different. Free thyroxine levels (FT4) (OR 1.266), higher left atrium volume (OR 1.113) and right ventricle diameter were associated with pulmonary hypertension. A direct correlation between FT4 with forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1), as also an inverse correlation between initial oxygen saturation (SpO2) with diagnostic time and drop SpO2 with the ratio between the diastolic velocity E of the mitral flow and the diastolic velocity of the mitral ring (E/e’) were observed in the euthyroid group. An inverse correlation between FT4 levels with walked distance as % of predicted value, and a direct correlation between E/e’ ratio and walked distance as % of predicted value were observed in the hyperthyroid group. CONCLUSION: We emphasize the importance of a cardiorespiratory reassessment in GD, even after a long-term control of the thyrotoxic state, as we demonstrate that about 30% of these patients remain with PH and are subject to specific treatment.
format Online
Article
Text
id pubmed-8772033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87720332022-01-21 Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients Araruna, Larisse Vieira Mendes de Oliveira, Daniela Camargo Pereira, Mônica Corso Moura Neto, Arnaldo Tambascia, Marcos Antonio Zantut-Wittmann, Denise Engelbrecht Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Graves’ disease (GD) is the most common cause of hyperthyroidism and can cause cardiac changes, such as pulmonary hypertension. METHODS: This is a prospective study in which we obtained demographic, clinical, laboratory data and characteristics of the GD, in addition to investigating cardiorespiratory function, focusing on the detection of pulmonary hypertension. Patients were separated into two groups: thyrotoxicosis and euthyroidism. Ninety patients with GD of both sexes, over 18 years of age, were included. The cardiorespiratory assessment included an echocardiographic evaluation, a questionnaire of specific symptoms, spirometry and a six-minute walk test. RESULTS: The hyperthyroid group included 42 patients (47.73%) and the euthyroid group 46 patients (52.27%); 78 were women (86.67%). The prevalence of pulmonary hypertension between the hyperthyroidism (48.57%) and the euthyroidism (29.41%) groups was not different. Free thyroxine levels (FT4) (OR 1.266), higher left atrium volume (OR 1.113) and right ventricle diameter were associated with pulmonary hypertension. A direct correlation between FT4 with forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1), as also an inverse correlation between initial oxygen saturation (SpO2) with diagnostic time and drop SpO2 with the ratio between the diastolic velocity E of the mitral flow and the diastolic velocity of the mitral ring (E/e’) were observed in the euthyroid group. An inverse correlation between FT4 levels with walked distance as % of predicted value, and a direct correlation between E/e’ ratio and walked distance as % of predicted value were observed in the hyperthyroid group. CONCLUSION: We emphasize the importance of a cardiorespiratory reassessment in GD, even after a long-term control of the thyrotoxic state, as we demonstrate that about 30% of these patients remain with PH and are subject to specific treatment. Frontiers Media S.A. 2022-01-06 /pmc/articles/PMC8772033/ /pubmed/35069439 http://dx.doi.org/10.3389/fendo.2021.780397 Text en Copyright © 2022 Araruna, Oliveira, Pereira, Moura Neto, Tambascia and Zantut-Wittmann https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Araruna, Larisse Vieira Mendes
de Oliveira, Daniela Camargo
Pereira, Mônica Corso
Moura Neto, Arnaldo
Tambascia, Marcos Antonio
Zantut-Wittmann, Denise Engelbrecht
Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
title Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
title_full Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
title_fullStr Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
title_full_unstemmed Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
title_short Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
title_sort interplay between thyroid hormone status and pulmonary hypertension in graves’ disease: relevance of the assessment in thyrotoxic and euthyroid patients
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772033/
https://www.ncbi.nlm.nih.gov/pubmed/35069439
http://dx.doi.org/10.3389/fendo.2021.780397
work_keys_str_mv AT ararunalarissevieiramendes interplaybetweenthyroidhormonestatusandpulmonaryhypertensioningravesdiseaserelevanceoftheassessmentinthyrotoxicandeuthyroidpatients
AT deoliveiradanielacamargo interplaybetweenthyroidhormonestatusandpulmonaryhypertensioningravesdiseaserelevanceoftheassessmentinthyrotoxicandeuthyroidpatients
AT pereiramonicacorso interplaybetweenthyroidhormonestatusandpulmonaryhypertensioningravesdiseaserelevanceoftheassessmentinthyrotoxicandeuthyroidpatients
AT mouranetoarnaldo interplaybetweenthyroidhormonestatusandpulmonaryhypertensioningravesdiseaserelevanceoftheassessmentinthyrotoxicandeuthyroidpatients
AT tambasciamarcosantonio interplaybetweenthyroidhormonestatusandpulmonaryhypertensioningravesdiseaserelevanceoftheassessmentinthyrotoxicandeuthyroidpatients
AT zantutwittmanndeniseengelbrecht interplaybetweenthyroidhormonestatusandpulmonaryhypertensioningravesdiseaserelevanceoftheassessmentinthyrotoxicandeuthyroidpatients